CLINICAL TRIALS PROFILE FOR DIPHEN
✉ Email this page to a colleague
All Clinical Trials for DIPHEN
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01158820 ↗ | Alternative Sedation During Bronchoscopy | Completed | Hospira, Inc. | Phase 4 | 2010-06-01 | This protocol hopes to determine whether the use of dexmedetomidine-ketamine can reduce the use of standard of care fentanyl-midazolam sedation during bronchoscopy. This may result in less respiratory depression while providing better compliance with the procedure. |
NCT01158820 ↗ | Alternative Sedation During Bronchoscopy | Completed | Hospira, now a wholly owned subsidiary of Pfizer | Phase 4 | 2010-06-01 | This protocol hopes to determine whether the use of dexmedetomidine-ketamine can reduce the use of standard of care fentanyl-midazolam sedation during bronchoscopy. This may result in less respiratory depression while providing better compliance with the procedure. |
NCT01158820 ↗ | Alternative Sedation During Bronchoscopy | Completed | University of Pennsylvania | Phase 4 | 2010-06-01 | This protocol hopes to determine whether the use of dexmedetomidine-ketamine can reduce the use of standard of care fentanyl-midazolam sedation during bronchoscopy. This may result in less respiratory depression while providing better compliance with the procedure. |
NCT01165866 ↗ | Ondansetron Versus Metoclopramide in Treatment of Vomiting in Gastroenteritis | Completed | Hamad Medical Corporation | Phase 4 | 2008-06-01 | Is intravenous metoclopramid as effective as intravenous ondansetron in the treatment of persistent vomiting in patients with acute gastroenteritis. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DIPHEN
Condition Name
Clinical Trial Locations for DIPHEN
Trials by Country
Clinical Trial Progress for DIPHEN
Clinical Trial Phase
Clinical Trial Sponsors for DIPHEN
Sponsor Name